Clinical Trial Update: Effect of Asimadoline, a Member of a New Medication Class, on Acute Attacks of Pain in Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing Asimadoline, a novel medication class, for reducing acute pain attacks in Irritable bowel syndrome. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Asimadoline (asimadoline)

Snippet

Sponsor: Mayo Clinic | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED